Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-12-019000
Filing Date
2012-03-19
Accepted
2012-03-19 16:41:13
Documents
2
Period of Report
2012-03-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3290
2 POA DOCUMENT poa.txt EX-24.4_416850 1825
  Complete submission text file 0001209191-12-019000.txt   6419
Mailing Address 1207 17TH AVENUE SUITE 103 NASHVILLE TN 37212
Business Address
KAZIMI A J (Reporting) CIK: 0001075050 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33637 | Film No.: 12700977

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Issuer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
SIC: 2834 Pharmaceutical Preparations